CRI has several HIV, hepatitis C (HCV) and other infectious disease clinical trials in progress at any one time at our Boston research facility. CRI’s clinical research helps find better ways to treat infectious diseases, fight drug resistance and lower the possible harm from side effects. It also helps people stay on their drugs for as long as they need and improves the simplicity of drug regimens so people can take fewer pills. Research improves the quality of HIV and HCV patient care on a global scale. If you have questions about CRI’s clinical trials or would like more information about currently enrolling clinical trials, click here or contact the CRI Research Team at 617.502.1707.